Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $129.10B.
ENTERPRISE VALUE (EV)
$129.10B
Vertex Pharmaceuticals Incorporated
Market Cap
$132.26B
Enterprise Value (EV)
$129.10B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $132.26B | $129.10B |
| Bristol-Myers Squibb Company (BMY)vs › | $131.57B | $166.54B |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.79B | $120.94B |
| CVS Health Corp. (CVS)vs › | $121.70B | $187.56B |
| Danaher Corporation (DHR)vs › | $144.11B | $166.46B |
| Medtronic plc (MDT)vs › | $117.62B | $144.73B |
| Pfizer Inc. (PFE)vs › | $158.33B | $220.61B |
| Stryker Corporation (SYK)vs › | $105.57B | $117.52B |
| McKesson Corporation (MCK)vs › | $104.40B | $110.63B |
| Sanofi (SNY)vs › | $102.89B | $123.30B |
Market Cap
$132.26B
Total Debt
$1.93B
Cash
$5.09B
Enterprise Value
$129.10B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
